Literature DB >> 16450092

Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia?

Joseph A Carcillo1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16450092     DOI： 10.1007/s00134-005-0067-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  25 in total

1.  Endotoxin-core antibodies: time for a reappraisal?

Authors:  G R Barclay
Journal:  Intensive Care Med       Date:  1999-05       Impact factor: 17.440

Review 2.  Endotoxin immunization.

Authors:  R Stephens; M Mythen
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

3.  The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery.

Authors:  M Rothenburger; R Soeparwata; M C Deng; E Berendes; C Schmid; T D Tjan; M J Wilhelm; M Erren; D Böcker; H H Scheld
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

4.  Preoperative and postoperative endotoxemia in children with congenital heart disease.

Authors:  L L Lequier; H Nikaidoh; S R Leonard; J L Bokovoy; M L White; P J Scannon; B P Giroir
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

5.  Mild endotoxaemia and the inflammatory response induced by a marathon race.

Authors:  G Camus; J Poortmans; M Nys; G Deby-Dupont; J Duchateau; C Deby; M Lamy
Journal:  Clin Sci (Lond)       Date:  1997-04       Impact factor: 6.124

6.  Exposure to bacteroides fragilis endotoxin during cardiac surgery.

Authors:  E Bennett-Guerrero; G R Barclay; M E Youssef; S Hossain; F Vela-Cantos; L A Andres; I R Poxton
Journal:  Anesth Analg       Date:  2000-04       Impact factor: 5.108

7.  Rises in antibody to enteric gram negative bacilli after open heart surgery: a possible mechanism for postoperative pyrexia.

Authors:  R Freeman; F K Gould
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

8.  Intramucosal acidosis and the inflammatory response in acute pancreatitis.

Authors:  C V Soong; H G Lewis; M I Halliday; B J Rowlands
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

9.  Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease.

Authors:  Zhong-yuan Xia; Xian-yi Liu; Li-ying Zhan; Yi-hong He; Tao Luo; Zhengyuan Xia
Journal:  J Thorac Cardiovasc Surg       Date:  2005-08       Impact factor: 5.209

10.  Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass.

Authors:  Naz Bige Aydin; Hakan Gercekoglu; Burak Aksu; Vedat Ozkul; Tufan Sener; Ilknur Kiygil; Tansel Turkoglu; Serdar Cimen; Funda Babacan; Murat Demirtas
Journal:  J Thorac Cardiovasc Surg       Date:  2003-04       Impact factor: 5.209
View more
  3 in total

Review 1.  Year in Review in Intensive Care Medicine, 2006. III. Circulation, ethics, cancer, outcome, education, nutrition, and pediatric and neonatal critical care.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-02-14       Impact factor: 17.440

2.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

Review 3.  The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation.

Authors:  Stephen F Lowry
Journal:  Surg Clin North Am       Date:  2009-04       Impact factor: 2.741
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.